HRT Access Under Threat: Why Funding Hormone Therapy Has Never Been More Urgent
As states restrict gender-affirming care and federal policy turns hostile, transgender people are losing access to hormone therapy. Here's what's happening and how donor funding saves lives.
Hormone replacement therapy is not optional for many transgender people. It is essential medical care that directly impacts mental health, physical wellbeing, and quality of life. Yet across the United States, access to HRT is being systematically restricted — and the consequences are severe.
The scope of the crisis
Twenty-seven states have enacted laws restricting gender-affirming care for minors, affecting an estimated 120,400 transgender young people. While the public debate has focused on youth, adults are increasingly impacted as well.
In Florida, restrictions on gender-affirming care have been extended to affect adult access. Published research documents patients being denied prescriptions they've used safely for years, pharmacies refusing to fill them, and providers dropping transgender patients from their practices out of legal fear.
In Missouri, similar dynamics are at play. Providers report that the chilling effect of restrictive legislation extends far beyond the letter of the law — even where adult HRT remains technically legal, many providers have stopped offering it.
The Supreme Court's Skrmetti ruling in June 2025 upheld Tennessee's ban on gender-affirming care for minors, emboldening other states to pursue further restrictions. Federal executive action has threatened Medicare and Medicaid funding for institutions providing gender-affirming care at any age.
What happens when HRT access is cut off
The medical evidence is clear: gender-affirming hormone therapy significantly improves quality of life, reduces depression and anxiety, and decreases suicidality among transgender people. Disrupting access to these treatments reverses those benefits.
When patients lose access to monitored, medically supervised HRT, some turn to unregulated hormone sources — purchasing medications online without medical oversight, dosing without lab work to monitor health markers, and managing side effects without professional guidance. This carries real medical risks including blood clots, liver damage, and cardiovascular complications.
Others simply go without. The mental health consequences of forced detransition or treatment interruption are well-documented and devastating.
Telehealth HRT is the lifeline
For transgender people in restrictive states, telehealth HRT providers operating under shield law protections have become the primary pathway to continued care.
Organizations like HRT@Home, based in the DC-Maryland area, prescribe hormone therapy via video telehealth to patients across 48 states — including states where in-person access to gender-affirming care has been restricted. Shield laws in DC and Maryland protect these providers from legal retaliation by restrictive states.
Other telehealth HRT providers include Plume, FOLX Health, and QueerDoc, each serving different state footprints and operating models.
The informed consent model used by most telehealth HRT providers — including HRT@Home — eliminates unnecessary gatekeeping. Patients meet with a provider, discuss their health history and goals, and begin treatment based on their informed decisions. No mental health referral, no letter from a therapist, no waiting period.
The cost barrier remains
Even where telehealth HRT is available, cost remains a significant barrier. Without insurance, a year of HRT can cost $1,000 to $3,000 including medications, provider visits, and lab work. Many telehealth HRT providers are cash-pay only, and sliding-scale programs — while helpful — don't cover everyone.
This is where donor funding makes the difference. CE Repro Fund provides direct financial assistance for transgender patients who cannot afford HRT. When someone in a restrictive state needs hormone therapy and can access it through a shield law provider but can't cover the cost, our funding bridges that gap.
How your donation funds HRT
$50 covers one month of HRT medication (estrogen, testosterone, or anti-androgens).
$100 covers a telehealth provider visit for initial consultation or ongoing monitoring.
$200 covers lab work — the blood tests that ensure hormones are at safe and effective levels.
$1,000 covers a full year of HRT including medications, provider visits, and lab monitoring.
These are concrete, measurable impacts. Your donation doesn't fund a marketing campaign or a lobbying effort — it funds someone's hormones. The medication that lets them be who they are.
How you can help
Donate to CE Repro Fund to directly fund HRT for transgender patients who can't afford care.
Share this post with your network. Many people who support transgender rights don't know that practical services like HRT funding exist.
Check our resources page for additional organizations supporting transgender healthcare access.
Gender-affirming care is healthcare. It's not political. It's not controversial among medical professionals. It's the standard of care recommended by every major medical organization in the world. And right now, donor funding is the only thing keeping many transgender people connected to it.